CAS 1264-62-6
:Eritromicina etilsuccinato
Descripción:
Eritromicina etilsuccinato es un antibiótico que pertenece a la clase de los macrólidos, utilizado principalmente para tratar diversas infecciones bacterianas. Es un derivado semisintético de la eritromicina, que mejora su estabilidad y biodisponibilidad. El compuesto se caracteriza por su capacidad para inhibir la síntesis de proteínas bacterianas al unirse a la subunidad ribosomal 50S, lo que lo hace efectivo contra una variedad de bacterias Gram-positivas y algunas Gram-negativas. Eritromicina etilsuccinato se administra típicamente por vía oral y a menudo se formula como un profármaco, que se convierte en eritromicina en el cuerpo. Se conoce por su toxicidad y efectos secundarios relativamente bajos, aunque pueden ocurrir trastornos gastrointestinales. La sustancia es soluble en disolventes orgánicos pero tiene una solubilidad limitada en agua, lo que influye en su formulación y entrega. Además, es importante considerar las posibles interacciones medicamentosas y los patrones de resistencia al usar este antibiótico en entornos clínicos. En general, Eritromicina etilsuccinato sigue siendo una opción valiosa en el tratamiento de infecciones, particularmente en pacientes que son alérgicos a la penicilina.
Fórmula:C43H75NO16
InChI:InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1
Clave InChI:InChIKey=NSYZCCDSJNWWJL-YXOIYICCSA-N
SMILES:O(C(CCC(OCC)=O)=O)[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C
Sinónimos:- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- EryPed
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 17 productos.
Erythromycin ethyl succinate
CAS:Erythromycin ethyl succinateFórmula:C43H75NO16Forma y color:Off-WhitePeso molecular:862.0527ERYTHROMYCIN ETHYLSUCCINATE RS
CAS:ERYTHROMYCIN ETHYLSUCCINATE RSFórmula:C43H75NO16Peso molecular:862.0527ERYTHROMYCIN ETHYLSUCCINATE CRS
CAS:ERYTHROMYCIN ETHYLSUCCINATE CRSFórmula:C43H75NO16Peso molecular:862.0527ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CRS
CAS:ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CRSFórmula:C43H75NO16Peso molecular:862.0527Erythromycin Ethylsuccinate
CAS:Erythromycin and its derivatives; salts thereofFórmula:C43H75NO16Forma y color:White PowderPeso molecular:861.50859(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-6-methyloxan-3-yl 1-ethyl butanedioate
CAS:Fórmula:C43H75NO16Forma y color:SolidPeso molecular:862.0527Erythromycin ethylsuccinate
CAS:Erythromycin ethylsuccinate (EES) is a macrolide antibiotic, produced by Streptomyces erythreus.Fórmula:C43H75NO16Pureza:77% - 98%Forma y color:White Or Slightly Yellow Crystalline Powder White To Yellowish Crystalline SolidPeso molecular:862.05Erythromycin Ethylsuccinate
CAS:<p>Erythromycin Ethylsuccinate</p>Pureza:≥765IU/mgPeso molecular:862.05g/molErythromycin Ethylsuccinate-13C-d3
CAS:Fórmula:C4213CH72D3NO16Forma y color:White To Off-White SolidPeso molecular:866.07Erythromycin Ethylsuccinate
CAS:Fórmula:C43H75NO16Forma y color:White To Off-White SolidPeso molecular:862.06Erythromycin-ethyl succinate
CAS:Producto controladoFórmula:C43H75NO16Forma y color:NeatPeso molecular:862.05Erythromycin Ethyl Succinate
CAS:Producto controlado<p>Applications Erythromycin Ethyl Succinate is a derivative of Erythromycin (E649950), an antibiotic.<br>References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979); Serisier, D. et al.: J. Am. Med. Assoc., 309, 1206 (2013);<br></p>Fórmula:C43H75NO16Forma y color:Off-WhitePeso molecular:862.05Erythromycin Ethyl Succinate-13C,d3
CAS:Producto controlado<p>Applications Erythromycin Ethyl Succinate-13C,d3 is the deuterated form of Erythromycin Ethyl Succinate (E649985), which is a derivative of Erythromycin (E649950), an antibiotic.<br>References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979); Serisier, D. et al.: J. Am. Med. Assoc., 309, 1206 (2013);<br></p>Fórmula:CC42D3H72NO16Forma y color:NeatPeso molecular:866.064Erythromycin ethyl succinate
CAS:<p>Erythromycin ethyl succinate is an ester prodrug that is formed by the reaction of erythromycin and ethylsuccinic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. Erythromycin ethyl succinate is also active against Haemophilus influenzae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, Helicobacter pylori, Leptospira interrogans, Bordetella pertussis, Rickettsia rickettsii, Borrelia burgdorferi, Coxiella burnetii, and Mycoplasma pneumoniae. Erythromycin ethyl succinate has been shown to be effective in treating streptococcal pharyngitis and tissue infections.</p>Fórmula:C43H75NO16Pureza:Min. 95%Peso molecular:862.05 g/mol











